Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02227940
Title Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Roswell Park Cancer Institute
Indications

Advanced Solid Tumor

pancreatic adenocarcinoma

Therapies

Ceritinib + Gemcitabine + Nab-paclitaxel

Ceritinib + Cisplatin + Gemcitabine

Ceritinib + Gemcitabine

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST